Biotech

All Articles

Editas capitalize Vertex Cas9 licensing rights for $57M

.Against the background of a Cas9 patent struggle that refuses to pass away, Editas Medicine is mone...

Ultragenyx changes gene therapy application to dial up efficacy

.A minority of clients taking Ultragenyx Drug's Wilson disease gene treatment UX701 have actually co...

Biopharma unemployment fee maintains in Q3: Ferocious Biotech study

.As summer season warm looks to cool down winds, wishes that this year would bring common business r...

J &amp J drops stage 2 dengue candidate in latest shift coming from vaccinations

.Johnson &amp Johnson's deprioritization of its own transmittable disease pipeline has actually decl...

Relay loses 10% of staff after earlier layoffs in July

.Precision medication biotech Relay Therapies is actually shedding around 10% of its own labor force...

Pentixapharm scores $22M IPO to advance radiopharma trials

.Pentixapharm has generated nearly twenty million europeans ($ 22 million) from an IPO, along with t...

Lundbeck water faucets Charles Waterway for AI-enabled neuro medicine finding

.Lundbeck has utilized Charles River Laboratories' artificial intelligence capacities to help the fi...

Big pharma, biotech 'will not essentially be symbiotic' in AI: S&ampP

.Large Pharma is actually committing highly in AI to slash progression timetables and foster innovat...

I &amp I biotech Triveni raises $115M for preclinical antitoxins

.Triveni Bio has actually roped in $115 thousand in series B funds to accelerate preclinical antitox...

IGM rotates from cancer cells to autoimmune, shaking up C-suite

.IGM Biosciences finished in 2014 laying off team and improving its own cancer cells pipeline. Now, ...